SCHEMBL66720

SCHEMBL66720

O[CH]C(O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6435140 0.74
SCHEMBL9573586 0.74
SCHEMBL8014451 0.72 AKR1B1 (0.53)
SCHEMBL8014456 0.72 AKR1B1 (0.53)
SCHEMBL28094225 0.72
SCHEMBL28108018 0.72
SCHEMBL5053913 0.72
SCHEMBL5152189 0.67
SCHEMBL284308 0.67
SCHEMBL1332346 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1676 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113462662-B Enzyme for preparing chiral tetrahydro beta-carboline and preparation method and application thereof 上海交通大学 2022-11-11 CN claimed
US-20200354518-A1 POLYMERIC ALPHA-HYDROXY ALDEHYDE AND KETONE REAGENTS AND CONJUGATION METHOD NEKTAR THERAPEUTICS (US) 2020-11-12 US claimed
EP-2331139-B1 POLYMERIC ALPHA-HYDROXY ALDEHYDE AND KETONE REAGENTS AND CONJUGATION METHOD NEKTAR THERAPEUTICS (US) 2019-04-17 EP claimed
EP-2996685-B1 ANTI-INFLUENZA COMPOSITIONS AND METHODS BIOCRYST PHARM INC (US) 2019-03-27 EP claimed
US-20180327546-A1 POLYMERIC ALPHA-HYDROXY ALDEHYDE AND KETONE REAGENTS AND CONJUGATION METHOD NEKTAR THERAPEUTICS 2018-11-15 US claimed
US-9862914-B2 Cleaning agent for semiconductor substrates and method for processing semiconductor substrate surface WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2018-01-09 US claimed
EP-3051577-B1 CLEANING AGENT FOR SEMICONDUCTOR SUBSTRATES AND METHOD FOR PROCESSING SEMICONDUCTOR SUBSTRATE SURFACE WAKO PURE CHEM IND LTD (JP) 2017-10-18 EP claimed
US-9716235-B2 9,10-bis[2-(p-substituted phenyl)pyrimidin-4-yl] anthracene compounds, methods of preparing the same, organic electroluminescent devices and organic electroluminescent display apparatus BOE TECHNOLOGY GROUP CO., LTD. (CN) 2017-07-25 US claimed
US-20170137429-A1 ANTI-INFLUENZA COMPOSITIONS AND METHODS BIOCRYST PHARMACEUTICALS, INC. 2017-05-18 US claimed
US-9527814-B2 Aromatic amine derivative, organic device material and hole-injection/transport material and organic electroluminescent element material each comprising the derivative, and organic electroluminescent element IDEMITSU KOSAN CO., LTD. (JP) 2016-12-27 US claimed
US-5380633-A A support with developers for photographic silver halide emulsions EASTMAN KODAK COMPANY (US) 1995-01-10 US claimed
EP-0606955-A2 Image formation in color reversal materials using weak and strong inhibitors EASTMAN KODAK COMPANY (US) 1994-07-20 EP claimed
EP-0428849-A2 Retroviral protease inhibitors HOECHST AKTIENGESELLSCHAFT (DE) 1991-05-29 EP claimed
CN-1050545-A Inhibitors of post-infective viral proteases HOECHST AG (DE) 1991-04-10 CN claimed
EP-0142517-B1 2-ACYLIMIDAZOLE COMPOUNDS, THEIR SYNTHESIS AND USE AS IMMUNOSUPPRESIVE MEDICINAL AGENTS THE COCA-COLA COMPANY (US) 1988-06-22 EP claimed
US-4567194-A IMMUNOSUPPRESSIVE AGENTS THE COCA-COLA COMPANY (US) 1986-01-28 US claimed
EP-0142517-A4 2-ACYLIMIDAZOLE COMPOUNDS, THEIR SYNTHESIS AND USE AS IMMUNOSUPPRESIVE MEDICINAL AGENTS. COCA COLA CO (US) 1985-07-30 EP claimed
EP-0142517-A1 2-ACYLIMIDAZOLE COMPOUNDS, THEIR SYNTHESIS AND USE AS IMMUNOSUPPRESIVE MEDICINAL AGENTS. COCA COLA CO (US) 1985-05-29 EP claimed
WO-1984003441-A1 2-ACYLIMIDAZOLE COMPOUNDS, THEIR SYNTHESIS AND USE AS IMMUNOSUPPRESIVE MEDICINAL AGENTS COCA COLA CO (US) 1984-09-13 WO claimed
EP-0007996-B1 4,6-DI-0-(AMINOGLYCOSYL)-1,3-DIAMINOCYCLITOLS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BAYER AG (DE) 1983-01-26 EP claimed